Prevention
Educational materials that cover preventative measures and harm reduction strategies to prevent the transmission of hepatitis C.
Materials in this section
Illicit Fentanyl Use Linked to Increased Risk of Hepatitis C Among People Who Use Drugs
Findings reveal shortfalls in hepatitis C elimination efforts in the United States and Mexico. More
Madrid-Based Study Shows Drop in HCV Rates Among Those Who Inject Drugs
A study from Spain reveals a decline in HCV infection rates among people who use drugs, suggesting that targeted screening programs are advancing the WHO goal of HCV elimination by 2030. More
Recording of the EMCDDA Webinar: Drug Consumption Rooms in Europe
In May 2024, the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) conducted a webinar to inform discussions on drug consumption rooms. More
Insights From Patient Who Cleared Hepatitis C Could Lead to Vaccine
By studying individuals who spontaneously clear hepatitis C infections, researchers have identified viable vaccine targets for a disease that infects 70 million worldwide with case numbers increasing every year. More
Prevalence of Hepatitis B and C, and Syphilis Among Aspirant Migrant Workers of Bangladesh
A study assesses the prevalence of hepatitis B, C, HIV, TB, syphilis, kidney and liver diseases along with presence of infections among aspirant migrant workers of Bangladesh. More
Future Prospects, Approaches, and the Government’s Role in the Development of a Hepatitis C Virus Vaccine
A review highlights the urgent need for a preventive HCV vaccine and the significance of collaborative efforts between scientists, politicians, and public health organizations to reach this important public health goal. More
Key Interventions to Prevent and Control Infections Among People Who Inject Drugs
In new public health guidance, the European Centre for Disease Prevention and Control and the European Monitoring Centre for Drugs and Drug Addiction have joined forces to identify key interventions to prevent and control infections among PWID. More
HIV PrEP as an Entry Point to the Elimination of Hepatitis B Virus
In the absence of dedicated funding mechanisms to address hepatitis B, PrEP programmes provide a strategic opportunity to implement critical interventions for hepatitis B in high-risk populations, so that hepatitis B can be eliminated by 2030. More
Harm Reduction: A Missing Piece to the Holistic Care of Patients Who Inject Drugs
A study evaluated the harm reduction counseling that infectious diseases physicians provide to PWID presenting with infections. More
How Did Egypt Eliminate Hepatitis C in Less Than One Year?
An analysis provides details of Egypt’s 100 Million Healthy Lives campaign which, with a modest loan from the World Bank, resulted in the elimination of hepatitis C. More
